Trials Sponsors Conditions Drugs Pricing

Conditions

Group B Streptococcal Infection Infection Due to ESBL Bacteria

Keywords

colonizationscreeninggroup B streptococciextended-spectrum beta-lactamaseenterobacteriaceae

Outcome Measures

Primary Outcomes (2)

Presence of group B streptococci in genital tract
on routine visit in third trimester of pregnancy
third trimester of pregnancy
Presence of colonizing extended-spectrum beta-lactamase enterobacteriaceae in genital tract
on routine visit in third trimester pregnancy
third trimester of pregnancy

Secondary Outcomes (4)

Evaluation of pain during performance of rectal swab
third trimester of pregnancy
Evaluation of discomfort during performance of rectal swab
third trimester of pregnancy
Evaluation of stress during performance of rectal swab
third trimester of pregnancy
risk factors for ESBL carriage
third trimester of pregnancy

Other Outcomes (2)

Evaluation of costs for additional rectal swab
between 38 and 42 gestational week
Resistance pattern of ESBL bacteria
between 38 and 42 gestational week

Study Arms (1)

rectal swab and vagino-perineal swab

OTHER

single-arm

Other: vagino-perineal swab

Interventions

vagino-perineal swabOther

rectal swab and vagino-perineal swab

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexfemale

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

third trimester pregnancy
must attend clinic for routine screening for group B streptococcus (GBS)

You may not qualify if:

Sponsors & Collaborators

Stiftung Forschung Infektionskrankheiten, Basel, Switzerland
Type not reportedcollaborator
University Hospital, Basel, Switzerland
Otherlead

Study Sites (1)

University Hospital Basel

Basel, 4031, Switzerland

MeSH Terms

Conditions

Streptococcal Infections

Condition Hierarchy (Ancestors)

Gram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfections

Study Officials

Irene Hoesli, Prof.
University Hospital, Basel, Switzerland
PRINCIPAL INVESTIGATOR

Enrollment

250 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: DIAGNOSTIC
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

May 16, 2014

First Posted

May 20, 2014

Study Start

November 2014

Date type not reported

This date has not been verified as actual or estimated.

Simplified GBS Screening and Prevalence of ESBL in Pregnant Women

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (4)

Other Outcomes (2)

Study Arms (1)

rectal swab and vagino-perineal swab

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (4)

Other Outcomes (2)

Study Arms (1)

rectal swab and vagino-perineal swab

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations